RNA therapeutics: clinical applications and methods of delivery
37 min
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Research interviews
-
25 min
1. Synthetic whole embryo models and their applications- Prof. Jacob (Yaqub) Hanna
-
31 min
2. Scale-up challenges in the production of nanomedicines from lab to industry- Prof. Dr. Oya Tagit
-
14 min
3. Artificial intelligence in precision medicine- Dr. Michael P. Menden
-
30 min
4. Translational medicine: the risk of failure in delay and how to reduce it- Prof. Martin Wehling
-
8 min
5. Challenges and solutions of scaling up- Dr. Shaukat Ali
-
15 min
-
31 min
7. Management of generic drug development: challenges and opportunities- Mr. Sandeep Patil
-
10 min
8. MassBank development and future- Dr. Emma L. Schymanski
-
31 min
9. Elite controllers of HIV: from discovery to future therapies- Prof. Bruce Walker
-
25 min
10. Translational research in amyotrophic lateral sclerosis (ALS)- Prof. Aaron D. Gitler
-
10 min
-
25 min
12. PANDAS: a potential link between group A streptococcal infections and neurological disorders- Prof. P. Patrick Cleary
-
29 min
13. Rheumatic diseases and musculoskeletal pain- Prof. Anisur Rahman
-
23 min
14. Towards developing a universal influenza vaccine- Prof. Peter Palese
- Clinical interviews
-
21 min
15. Monkeypox: etiopathogenesis, prevention, and treatments- Dr. Dennis Hruby
-
13 min
16. Kidney xenotransplantation- Dr. Douglas J. Anderson
-
28 min
17. CAR-T and TCR-T cellular immunotherapies in oncology- Prof. Sebastian Kobold
-
28 min
18. MAPS: the business of medical affairs- Dr. Danie du Plessis
-
26 min
19. Hypertrophic cardiomyopathy: therapies and treatments- Prof. Srihari Naidu
-
24 min
20. Combating the HIV epidemic- Prof. William Blattner
-
17 min
21. Epigenetic pharmaceuticals used in the clinic- Dr. Thomas Paul
-
21 min
22. Precision cancer medicine: development and future- Prof. Maurie Markman
-
31 min
23. Pediatric cancer testing- Prof. Joshua Schiffman
-
27 min
24. Opposition to vaccination: a transatlantic discussion- Prof. Jonathan Temte
-
26 min
25. Elective caesarean sections from an evolutionary perspective- Prof. Wenda Trevathan
-
19 min
26. Antiphospholipid syndrome and Lupus- Prof. Graham Hughes
-
16 min
27. Prescribing medications to children - a GP’s view- Dr. Amanda Simmons
Topics Covered
- The development of naked and drug-conjugated antibodies against endoglin and CD75b
- The results of recent clinical trials with both therapeutic antibodies
- Advantages and challenges in the development of naked and drug-conjugated antibodies
Biography
Ben K. Seon is a Professor of Immunology and Oncology. He is a nationally and internationally recognized cancer researcher whose main research has been on the development of unique monoclonal antibodies that define novel tumor associated antigens or novel epitopes of tumor associated antigens and application of these monoclonal antibodies and their immunoconjugates for cancer therapy. Recent focus of his studies has been on translational research in the fields of antibody-based anti-angiogenic and vascular targeting therapy of cancer by targeting endoglin (CD105), which he co-discovered.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Seon, B. (2020, September 16). The development of therapeutic antibodies against oncogenic antigens [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 23, 2024, from https://hstalks.com/bs/3776/.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Ben Seon has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Audio Interview
The development of therapeutic antibodies against oncogenic antigens
Published on September 16, 2020
15 min
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...